RLMD
Relmada Therapeutics Inc.
$1.66
+$0.01(+0.61%)
36
Overall
--
Value
36
Tech
--
Quality
Market Cap
$50.78M
Volume
266.10K
52W Range
$0.24 - $3.98
Target Price
$1.00
EPS Estimates Overview
| Current Quarter | $-0.04 | Next Quarter | $-0.03 |
| Current Year | $NA | Next Year | $-0.05 |
| QoQ Growth | +25.0% | YoY Growth | NaN% |
| 3Y EPS CAGR | +28.2% | Target Price | $1.00 |
| Consensus | Buy | Upside | -39.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RLMD | $1.66 | +0.6% | 266.10K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Relmada Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW